Pharmaceutical Preparations · E9 · CIK 1801198
Develops and commercializes cell therapies for cancer
Comparable business profile · signals at a glance
In the 90 days to Jun 25, 2026: 1 sold $82K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 25, 2026 | Huang YingChief Executive Officer | Sell | 5,566 | $14.78 | $82K |
| Mar 25, 2026 | Huang YingChief Executive Officer | Sell | 9,936 | $8.77 | $87K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Coverage (30d): 1 reputable article · skews ▲ positive.
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗